Goldman Sachs’s 4D Molecular Therapeutics FDMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.4M | Sell |
4,159,264
-9,130
| -0.2% | -$33.9K | ﹤0.01% | 1950 |
|
|
2025
Q1 | $13.5M | Sell |
4,168,394
-106,579
| -2% | -$344K | ﹤0.01% | 1998 |
|
|
2024
Q4 | $23.8M | Buy |
4,274,973
+683,943
| +19% | +$3.81M | ﹤0.01% | 1638 |
|
|
2024
Q3 | $38.8M | Sell |
3,591,030
-543,224
| -13% | -$5.87M | 0.01% | 1245 |
|
|
2024
Q2 | $86.8M | Buy |
4,134,254
+1,076,405
| +35% | +$22.6M | 0.01% | 758 |
|
|
2024
Q1 | $97.4M | Buy |
3,057,849
+2,241,506
| +275% | +$71.4M | 0.02% | 683 |
|
|
2023
Q4 | $16.5M | Buy |
816,343
+658,069
| +416% | +$13.3M | ﹤0.01% | 1712 |
|
|
2023
Q3 | $2.01M | Sell |
158,274
-35,991
| -19% | -$458K | ﹤0.01% | 3093 |
|
|
2023
Q2 | $3.51M | Sell |
194,265
-3,537
| -2% | -$63.9K | ﹤0.01% | 2820 |
|
|
2023
Q1 | $3.4M | Buy |
197,802
+79,458
| +67% | +$1.37M | ﹤0.01% | 2829 |
|
|
2022
Q4 | $2.63M | Buy |
118,344
+13,274
| +13% | +$295K | ﹤0.01% | 3086 |
|
|
2022
Q3 | $844K | Sell |
105,070
-28,493
| -21% | -$229K | ﹤0.01% | 3930 |
|
|
2022
Q2 | $932K | Buy |
133,563
+58,105
| +77% | +$405K | ﹤0.01% | 3998 |
|
|
2022
Q1 | $1.14M | Buy |
75,458
+41,963
| +125% | +$635K | ﹤0.01% | 4006 |
|
|
2021
Q4 | $735K | Buy |
33,495
+23,809
| +246% | +$522K | ﹤0.01% | 4254 |
|
|
2021
Q3 | $261K | Buy |
+9,686
| New | +$261K | ﹤0.01% | 4739 |
|
|
2021
Q2 | – | Sell |
-12,486
| Closed | -$542K | – | 5414 |
|
|
2021
Q1 | $542K | Sell |
12,486
-62,492
| -83% | -$2.71M | ﹤0.01% | 4298 |
|
|
2020
Q4 | $3.11M | Buy |
+74,978
| New | +$3.11M | ﹤0.01% | 2794 |
|